Carbonic Anhydrase Inhibitor [EPC]

20245 reported adverse events

Drugs of this class: ACETAZOLAMIDE BRINZOLAMIDE DICHLORPHENAMIDE ACETAZOLAMIDE EXTENDED-RELEASE BRINZOLAMIDE/BRIMONIDINE TARTRATE

These side effects are most commonly reported by patients taking drugs of the Carbonic Anhydrase Inhibitor [EPC] class:

# Side effect Count
0 TREATMENT FAILURE 1812
1 DRUG INEFFECTIVE 1560
2 OFF LABEL USE 1166
3 FATIGUE 1129
4 DYSPNOEA 1013
5 DIZZINESS 969
6 HEADACHE 946
7 NAUSEA 830
8 EYE PAIN 809
9 VISION BLURRED 809
See all common reactions for Carbonic Anhydrase Inhibitor [EPC]

Drugs of the Carbonic Anhydrase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 231 0.2145
1 CHOROIDAL EFFUSION 91 0.1133
2 EYE ALLERGY 125 0.0806
3 INTRAOCULAR PRESSURE INCREASED 631 0.0493
4 URINARY TRACT DISORDER 200 0.0444
5 ANGLE CLOSURE GLAUCOMA 108 0.0423
6 CORNEAL OEDEMA 85 0.0379
7 HAEMORRHAGIC STROKE 257 0.0329
8 OCULAR DISCOMFORT 360 0.0320
9 GLAUCOMA 505 0.0262
See all enriched reactions for Carbonic Anhydrase Inhibitor [EPC]